News

At week 4, all participants were assigned intravitreous bevacizumab (1.25mg). The researchers found that BCVA improved 9.8 letters with lamivudine and decreased 1.8 letters with placebo at 4 weeks.
MONDAY, June 2, 2025 (HealthDay News) -- For patients with center-involved diabetic macular edema (CI-DME), lamivudine improves visual acuity, according to a study published online May 27 in Med ...
Stephen Stanko, a South Carolina death row inmate, chose lethal injection after a firing squad execution was criticized as "botched" and raised concerns about execution methods.
A single intravitreal injection of UBX1325 (foselutoclax) was shown to be safe in patients with diabetic macular edema. The drug also showed potential efficacy in patients who failed to optimally ...
NEWTON, Mass., January 15, 2025--First-in-class dual inflammasome inhibitor demonstrates rapid, substantial and significant efficacy, and safety in 3 mo. trial in geographic atrophy ...
In a U.S. clinical trial of 5 patients with bilateral GA, sustained-release intravitreous implants of K8 were well tolerated, with no drug-related ocular or systemic serious adverse events.
Expected to treat up to five subjects with intravitreous injection of intraocular implant designed to last for three months. ... the drugs require an intraocular injection every four to eight weeks.
“Multivariate logistic regression analysis showed that a greater number of previous anti-VEGF injections (odds ratio [OR]: 1.12, P = 0.006; area under the curve: 0.82, cut-off score, 14.0) and an ...
The investigators found that the number of previous anti-VEGF injections before administration of brolucizumab was greater in the patients in whom intraocular inflammation developed (P = 0.004). In ...
YANTAI, China, March 13, 2023 /PRNewswire/ -- Luye Pharma Group today announced that patient enrollment has been completed for the Phase 3 clinical study (comparative clinical study of efficacy and ...
More information: Four-Year Visual Outcomes in the Protocol W Randomized Trial of Intravitreous Aflibercept for Prevention of Vision-Threatening Complications of Diabetic Retinopathy, JAMA (2023 ...
KOLOA, Hawaii — Having a standard method of communication in place for staff helps prevent wrong intravitreous injections, according to a speaker here. During a Retina 2023 presentation, Robin A ...